PropThink: Puma’s Quarterly Reveals Catalysts Around the Corner

[ACN Newswire] – By Jake KingPuma Biotechnology (NYSE:PBYI) made waves last month when it uplisted to the NYSE and initiated a substantial capital raise, increasing cash and equivalents to approximately $162 million, and … more

View todays social media effects on PBYI

View the latest stocks trending across Twitter. Click to view dashboard